Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G2CQ
|
||||
Former ID |
DIB000202
|
||||
Drug Name |
WC-3027
|
||||
Synonyms |
SEGRA, Warner Chilcott; SEGRA, Warner Chilcott/Schering AG; Selective glucocorticoid receptor agonist (dermatitis), Warner Chilcott; Selective glucocorticoid receptor agonist (dermatitis), Warner Chilcott/Schering AG
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Discontinued in Phase 2 | [548039] | ||
Company |
AstraZeneca
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Agonist | [548040] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.